The impact of adjuvant therapy on outcome in UICC stage I pancreatic cancer

Adjuvant chemotherapy has become standard of care for pancreatic ductal adenocarcinoma (PDAC) as it improves patient outcome. However, its clinical meaning in early‐stage, UICC I tumors remains uncertain. We examined the effect of adjuvant therapy on disease‐free survival (DFS) and overall survival...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	International journal of cancer 2022-09, Vol.151 (6), p.914-919
Hauptverfasser:	Guenther, Michael, Boeck, Stefan, Heinemann, Volker, Werner, Jens, Engel, Jutta, Ormanns, Steffen
Format:	Artikel
Sprache:	eng
Schlagworte:	Adenocarcinoma Adjuvant therapy Cancer Carcinoma, Pancreatic Ductal - drug therapy Chemotherapy Chemotherapy, Adjuvant Child Child, Preschool early‐stage pancreatic cancer Female Humans Localization Male Medical research Neoplasm Staging outcome Pancreatic cancer Pancreatic Neoplasms Pancreatic Neoplasms - drug therapy Patients Retrospective Studies Survival Survival Rate Tumors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!